Flavia Ejzykowicz
About Flavia Ejzykowicz
Flavia Ejzykowicz is the Director, WW HEOR RCC Lead at Bristol-Myers Squibb, with extensive experience in health economics and outcomes research, particularly in oncology and diabetes.
Current Position at Bristol-Myers Squibb
Flavia Ejzykowicz holds the title of Director, WW HEOR RCC Lead at Bristol-Myers Squibb. As the lead for Health Economics and Outcomes Research (HEOR) for Renal Cell Carcinoma (RCC), she has been responsible for overseeing initiatives and projects in this specific therapeutic area since January 2020. Her role involves leading a team dedicated to developing health economic models and generating real-world evidence that supports the value of RCC treatments.
Previous Roles at Merck
Flavia Ejzykowicz has an extensive history with Merck, having held multiple roles from 2012 to 2020. She started as a Postdoc Fellow from 2012 to 2014, focusing on oncology outcomes research. She then transitioned to Associate Director - CORE Diabetes from 2014 to 2018, leading health economic evaluations for diabetes treatments. From 2018 to 2020, she served as Associate Director, CORE Oncology in Rahway, New Jersey, where she continued to develop health economic models and real-world evidence for oncology.
Educational Background
Flavia Ejzykowicz obtained her Doctor of Philosophy (PhD) in Pharmaceutical Economics and Policy from the University of Southern California from 2008 to 2012. Prior to that, she completed her M.Sc in Pharmaceutical Economics at the same university from 2006 to 2008. Her foundational education includes a B.S in Pharmacy from Universidade Federal do Rio de Janeiro, which she earned between 2000 and 2005.
Early Career and Consulting Experience
Flavia Ejzykowicz gained significant early career experience in various capacities. She worked as a Health Economist - Contractor at Genentech from 2011 to 2012, focusing on economic modeling and cost-effectiveness analysis. She also held a consulting role at Xcenda from 2008 to 2009, providing strategic insights and economic evaluations for pharmaceutical clients. Additionally, she worked as a Scientific Advisor intern at GlaxoSmithKline, contributing to pharmaceutical research and development from 2003 to 2005.
Research Experience at University of Southern California
During her time at the University of Southern California, Flavia Ejzykowicz was deeply involved in research. She served as a Research Assistant from 2006 to 2012 and pursued her PhD studies in Pharmaceutical Economics and Policy from 2008 to 2012. Her research work during this period laid a strong foundation for her subsequent roles in health economics and outcomes research in the pharmaceutical industry.